An Open-Label Study to Assess the Long-Term Safety of Solriamfetol in Children and Adolescents With ADHD
Clinical trial NCT07773883 · ENROLLING_BY_INVITATION
Trial details
- NCT number
- NCT07773883
- Sponsor
- Axsome Therapeutics, Inc.
- Status
- ENROLLING_BY_INVITATION
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2026-08-06
- Primary completion
- 2027-12-01
- Enrollment
- 300
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.